Black Diamond Therapeutics (BDTX) Asset Utilization Ratio (2025)

Black Diamond Therapeutics' (BDTX) quarterly Asset Utilization Ratio came in at 0.47 in Q4 2025, up 7.77% on a QoQ basis from 0.43 in Q3 2025.

Black Diamond Therapeutics (BDTX) Asset Utilization Ratio (2025) Analysis & Trends

Black Diamond Therapeutics (BDTX) has 1 years of Asset Utilization Ratio data on file, last reported at 0.47 in Q4 2025.

Quarterly Asset Utilization Ratio changed N/A year-over-year to 0.47 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.47 (changed N/A YoY) and the FY2025 annual result came in at 0.53, changed N/A from the prior year.
Asset Utilization Ratio grew to 0.47 in Q4 2025, from 0.43 in the prior quarter.
In the past five years, Asset Utilization Ratio ranged from a high of 0.47 in Q1 2025 to a low of 0.41 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Asset Util. (Qtr)
1	Vertex Pharmaceuticals	138.54 Bn	130.69 Bn	2.84 Bn	0.47
2	Regeneron Pharmaceuticals	85.89 Bn	77.89 Bn	3.93 Bn	0.38
3	Argenx Se	64.84 Bn	59.65 Bn	1.37 Bn	-
4	Moderna	56.53 Bn	51.39 Bn	52.00 Mn	0.20
5	BeOne Medicines	41.97 Bn	36.87 Bn	1.53 Bn	0.69
6	Alnylam Pharmaceuticals	31.53 Bn	28.22 Bn	992.69 Mn	0.90
7	BioNTech SE	27.70 Bn	9.31 Bn	668.28 Mn	0.13
8	Insmed	27.45 Bn	26.29 Bn	358.27 Mn	0.54
9	Royalty Pharma	27.33 Bn	26.49 Bn	-	0.13
10	Black Diamond Therapeutics	125.35 Mn	14.84 Mn	-	-

Download Data